-
February 12, 2013
UCB (UCBJF) and Amgen Inc. (AMGN) recently announced their decision to discontinue a phase III program being ...
-
February 08, 2013
Avanir Pharmaceuticals, Inc. (AVNR) reported first quarter fiscal 2013 net loss per share of 9 cents, wider than the ...
-
February 06, 2013
ArQule, Inc. (ARQL) and partner Daiichi Sankyo recently announced that former has enrolled the first patient for the ...
-
February 06, 2013
Good news flowed in at UCB (UCBJF) from Europe when the European Union (EU) approved Vimpat (lacosamide) as a single ...
-
February 04, 2013
Valeant Pharmaceuticals International, Inc. (VRX) recently closed the acquisition of Russia-based Natur Produkt ...
-
January 31, 2013
Auxilium Pharmaceuticals, Inc. (AUXL) recently announced the initiation of a patent infringement lawsuit against ...
-
January 30, 2013
Anacor Pharmaceuticals, Inc. (ANAC) recently announced positive preliminary results on tavaborole (AN2690) from ...
-
January 30, 2013
ARIAD Pharmaceuticals, Inc. (ARIA) recently announced the closure of its previously announced public offering. ARIAD ...
-
January 29, 2013
Seattle Genetics, Inc. (SGEN) recently presented interim results from a phase I study which is evaluating ASG-5ME ...
-
January 23, 2013
Novo Nordisk (NVO) recently announced that it has received approval in the EU (covering all 27 states) for its ...
-
January 23, 2013
Novartis' (NVS) global eye care division, Alcon, recently received a positive opinion from the Committee for ...
-
January 23, 2013
Impax Laboratories, Inc. (IPXL) received a major setback recently with the US Food and Drug Administration (FDA) ...
-
January 18, 2013
Onyx Pharmaceuticals, Inc. (ONXX) recently announced its intention to raise funds through the issuance of 4.4 ...
-
January 07, 2013
Salix Pharmaceuticals, Ltd. (SLXP) recently said that the FDA has approved the company's anti-diarrhea drug for ...
-
November 30, 2012
This morning's trading has marked a bad day for the market so far. The Nasdaq has decreased 0.4%; the S&P 500 has ...
-
November 27, 2012
The market is currently down, with the Nasdaq declining 0.2%, the S&P 500 slipping 0.2% and the Dow down 0.3%. The ...
-
November 12, 2012
Salix Pharmaceuticals, Ltd. (SLXP) posted third quarter earnings of 95 cents per share, well above the Zacks ...
-
November 08, 2012
The market is having a bad day so far: the Nasdaq has slipped 0.5%; the S&P 500 is trading down 0.2%; and the Dow ...
-
November 08, 2012
This morning's trading has marked a bad day for the market so far. The Nasdaq has fallen 0.5%; the S&P 500 is down ...
-
November 07, 2012
Can Endo reestablish itself as a quality healthcare name?
